Search
Results: 3
Prediction and clinical utility of a contralateral breast cancer risk model.
Daniele Giardiello, Ewout W Steyerberg, Michael Hauptmann, Muriel A Adank, Delal Akdeniz, Carl Blomqvist, Stig E Bojesen, Manjeet K Bolla, Mariël Brinkhuis, Jenny Chang-Claude, Kamila Czene, Peter Devilee, Alison M Dunning, Douglas F Easton, Diana M Eccles, Peter A Fasching, Jonine Figueroa, Henrik Flyger, Montserrat García-Closas, Lothar Haeberle, Christopher A Haiman, Per Hall, Ute Hamann, John L Hopper, Agnes Jager, Anna Jakubowska, Audrey Jung, Renske Keeman, Iris Kramer, Diether Lambrechts, Loic Le Marchand, Annika Lindblom, Jan Lubiński, Mehdi Manoochehri, Luigi Mariani, Heli Nevanlinna, Hester SA Oldenburg, Saskia Pelders, Paul DP Pharoah, Mitul Shah, Sabine Siesling, Vincent THBM Smit, Melissa C Southey, William J Tapper, Rob AEM Tollenaar, Alexandra J van den Broek, Carolien HM van Deurzen, Flora E van Leeuwen, Chantal Van Ongeval, Laura J Van't Veer, Qin Wang, Camilla Wendt, Pieter J Westenend, Maartje J Hooning, Marjanka K Schmidt
Jan 20, 2020
BACKGROUND: Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the consequent burden of further treatment and potentially less favorable prognosis. We aimed to develop and validate a CBC risk...
Brca Mutation Carriers Clinical Decision-Making Contralateral breast cancer Risk prediction model Area Under Curve BRCA1 Protein BRCA2 Protein Breast Neoplasms Clinical Decision-Making Disease Management Disease Susceptibility Female Germ-Line Mutation Humans Neoplasms Second Primary Netherlands Prognosis Proportional Hazards Models Risk Assessment Risk Factors
Prediction and clinical utility of a contralateral breast cancer risk model
Daniele Giardiello, Ewout W. Steyerberg, Michael Hauptmann, Muriel A. Adank, Delal Akdeniz, Carl Blomqvist, Stig E. Bojesen, Manjeet K. Bolla, Mariël Brinkhuis, Jenny Chang-Claude, Kamila Czene, Peter Devilee, Alison M. Dunning, Douglas F. Easton, Diana M. Eccles, Peter A. Fasching, Jonine Figueroa, Henrik Flyger, Montserrat García-Closas, Lothar Haeberle, Christopher A. Haiman, Per Hall, Ute Hamann, John L. Hopper, Agnes Jager, Anna Jakubowska, Audrey Jung, Renske Keeman, Iris Kramer, Diether Lambrechts, Loic Le Marchand, Annika Lindblom, Jan Lubiński, Mehdi Manoochehri, Luigi Mariani, Heli Nevanlinna, Hester S. A. Oldenburg, Saskia Pelders, Paul D. P. Pharoah, Mitul Shah, Sabine Siesling, Vincent T. H. B. M. Smit, Melissa C. Southey, William J. Tapper, Rob A. E. M. Tollenaar, Alexandra J. van den Broek, Carolien H. M. van Deurzen, Flora E. Van Leeuwen, Chantal Van Ongeval, Laura J. Van’t Veer, Qin Wang, Camilla Wendt, Pieter J. Westenend, Maartje J. Hooning, Marjanka K. Schmidt
Dec 22, 2020
Abstract: Background: Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the consequent burden of further treatment and potentially less favorable prognosis. We aimed to develop and validate a CBC...
Prediction and clinical utility of a contralateral breast cancer risk model.
Daniele Giardiello, Ewout W Steyerberg, Michael Hauptmann, Muriel A Adank, Delal Akdeniz, Carl Blomqvist, Stig E Bojesen, Manjeet K Bolla, Mariël Brinkhuis, Jenny Chang-Claude, Kamila Czene, Peter Devilee, Alison M Dunning, Douglas F Easton, Diana M Eccles, Peter A Fasching, Jonine Figueroa, Henrik Flyger, Montserrat García-Closas, Lothar Haeberle, Christopher A Haiman, Per Hall, Ute Hamann, John L Hopper, Agnes Jager, Anna Jakubowska, Audrey Jung, Renske Keeman, Iris Kramer, Diether Lambrechts, Loic Le Marchand, Annika Lindblom, Jan Lubiński, Mehdi Manoochehri, Luigi Mariani, Heli Nevanlinna, Hester S A Oldenburg, Saskia Pelders, Paul D P Pharoah, Mitul Shah, Sabine Siesling, Vincent T H B M Smit, Melissa C Southey, William J Tapper, Rob A E M Tollenaar, Alexandra J van den Broek, Carolien H M van Deurzen, Flora E van Leeuwen, Chantal Van Ongeval, Laura J Van't Veer, Qin Wang, Camilla Wendt, Pieter J Westenend, Maartje J Hooning, Marjanka K Schmidt
Jan 27, 2020
BACKGROUND:Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the consequent burden of further treatment and potentially less favorable prognosis. We aimed to develop and validate a CBC risk...